CMAB Biopharma (Suzhou) Inc., a biologics contract manufacturing and development organization (CDMO), has appointed Ye Shi as the head of quality. He will be responsible for the overall management of the quality system within CMAB.   Yongzhong Wang, chief executive officer, CMAB, said, “We are very pleased to welcome Mr. Ye Shi to CMAB. In the Chinese biopharmaceutical and CDMO industries, quality experts like Mr. Ye Shi are very rare. He has both front-line practical experience as well as succe...